Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is designed to determine whether intratracheal administration of budesonide combined with surfactant, as compared to surfactant alone, will modify ecographic (lung ultrasound score) and biological markers (IL-6 concentration in respiratory secretions) at 7 days of life in preterm infants ≤32 weeks of gestational age (GA).
Epistemonikos ID: 1975556e3dadd3927b0ee7c950584452c69d9087
First added on: May 08, 2024